No profile data available.
Cannabis Strategic Ventures (NUGS) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Los Angeles, United States, with about 30 full-time employees.
It reported revenue of $2.37 million for fiscal year 2020, up 237.2% from fiscal year 2019, and net income of -$9.06 million. In Q1 2021 (the quarter ended June 30, 2020) revenue was $3.37 million, up 1992.7% from a year before. Its market capitalization was $2.13 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2020; market data as of October 8, 2026.
Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.
Cannabis Strategic Ventures reported $2.37 million in revenue for fiscal year 2020, up 237.2% from $701,968 in fiscal year 2019. In Q1 2021 revenue was $3.37 million.
$2.13 million as of October 8, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Sohm, Inc. (SHMN), North American Cannabis Holdings, Inc. (USMJ), Marijuana Company of America, Inc. (MCOA), Rafarma Pharmaceuticals, Inc. (RAFA).